FNY Investment Advisers’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 988 |
|
|
2024
Q2 | – | Sell |
-100
| Closed | -$1 | – | 568 |
|
|
2024
Q1 | $1 | Hold |
100
| – | – | ﹤0.01% | 586 |
|
|
2023
Q4 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 390 |
|
|
2023
Q3 | – | Sell |
-100
| Closed | – | – | 635 |
|
|
2023
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 585 |
|
|
2023
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 626 |
|
|
2022
Q4 | $0 | Sell |
100
-150
| -60% | – | ﹤0.01% | 563 |
|
|
2022
Q3 | $1K | Hold |
250
| – | – | ﹤0.01% | 544 |
|
|
2022
Q2 | $2K | Sell |
250
-250
| -50% | -$2K | ﹤0.01% | 531 |
|
|
2022
Q1 | $4K | Sell |
500
-600
| -55% | -$4.8K | ﹤0.01% | 517 |
|
|
2021
Q4 | $11K | Buy |
1,100
+300
| +38% | +$3K | 0.01% | 346 |
|
|
2021
Q3 | $15K | Buy |
800
+500
| +167% | +$9.38K | 0.01% | 489 |
|
|
2021
Q2 | $5K | Sell |
300
-5,900
| -95% | -$98.3K | ﹤0.01% | 587 |
|
|
2021
Q1 | $73K | Buy |
6,200
+1,800
| +41% | +$21.2K | 0.03% | 370 |
|
|
2020
Q4 | $75K | Buy |
4,400
+800
| +22% | +$13.6K | 0.02% | 317 |
|
|
2020
Q3 | $37K | Buy |
3,600
+2,600
| +260% | +$26.7K | 0.02% | 257 |
|
|
2020
Q2 | $5K | Buy |
+1,000
| New | +$5K | ﹤0.01% | 306 |
|
|
2019
Q2 | – | Sell |
-200
| Closed | -$1K | – | 988 |
|
|
2019
Q1 | $1K | Buy |
+200
| New | +$1K | ﹤0.01% | 585 |
|